Perrigo | PRGO - Interest Expense On Debt


Perrigo reported $10.08B in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
AbbVie USD 740M 40M Jun/2025
Abbott USD 68M 26M Mar/2026
Bayer EUR 675M 87M Dec/2025
Bristol-Myers Squibb USD 432M 48M Dec/2025
Coherus Biosciences USD 2.25M 76K Dec/2025
Corcept Therapeutics USD 823.61M 21.88M Sep/2025
Dr.Reddys Laboratories INR 944M 37M Dec/2025
Eli Lilly USD 114.7M 134.3M Sep/2025
J&J USD 43M 25M Mar/2026
Merck USD 412M 85M Dec/2025
Nestle CHF 897M 32M Dec/2025
Pacira USD 3.89M 387K Dec/2025
Perrigo USD 10.08B 10.04B Sep/2025
Pfizer USD 711M 59M Dec/2025
Phibro Animal Health USD 11.91M 191K Dec/2025
Prestige Brands USD 10.67M 636K Dec/2025
Reckitt Benckiser GBP 208M 198.3M Dec/2024
Sanofi EUR 178M 203M Mar/2026
Supernus Pharmaceuticals USD 910K 278K Jun/2023
Teva Pharmaceutical Industries USD 220M 17M Dec/2025
Xeris Pharmaceuticals USD 7.15M 115K Dec/2025
Zoetis USD 57M 1000K Dec/2025